Listed by the USPTO as HOPPE, EMMA RUTH
Tech Center 1600 • Art Units: 1682 1683
This examiner grants 40% of resolved cases
HOPPE, EMMA RUTH is assigned to Tech Center 1600 and Art Unit 1682. The profile covers 40 resolved cases, with a 40.0% allowance rate and a median of 1418 days to allowance. The 58.3% interview lift indicates a substantially higher allowance outcome for cases involving interviews in this dataset.
The listed companies are The Board of Trustees of the Leland Stanford Junior University, Bio-Rad Laboratories Inc., and Raytheon Technologies Corporation. The listed firms are Cantor Colburn LLP - Raytheon, Lathrop GPM LLP, and SALIWANCHIK, LLOYD & EISENSCHENK. The allowance rate indicates that claim strategy requires close attention, while the interview measure supports preparing carefully for direct examiner engagement. The limited case record makes application-specific analysis important, and the median timing supports early docket planning.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17908634 | PREDICTION OF RADIOTHERAPY RESPONSE FOR PROSTATE CANCER SUBJECT BASED ON IMMUNE DEFENSE RESPONSE GENES | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18251033 | METHOD FOR DETERMINING SENSITIVITY TO PARP INHIBITOR OR DNA DAMAGING AGENT USING NON-FUNCTIONAL TRANSCRIPTOME | Final Rejection | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18320148 | Systems and Methods for Assessing Mutational Burden of Neoplasms And Associated Treatments Thereof | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17822028 | Systems and Methods for Protecting Nucleic Acid Molecules | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17498627 | HIGHLY-MULTIPLEXED FLUORESCENT IMAGING | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18246529 | SIMULTANEOUS AMPLIFICATION OF DNA AND RNA FROM SINGLE CELLS | Final Rejection | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY |
| 17541117 | CLOSED NUCLEIC ACID STRUCTURES | Non-Final OA | GEN-PROBE INCORPORATED |
| 18076279 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY IN BREAST CANCER SUBTYPES | Non-Final OA | Myriad Genetics, Inc. |
| 17576975 | LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM | Final Rejection | Raytheon BBN Technologies, Corp. |
| 17576973 | LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM | Final Rejection | Raytheon BBN Technologies, Corp. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy40.0% of resolved applications examined by Emma Ruth Hoppe were allowed (40 resolved cases), compared with 41.5% across Art Unit 1682 over the last five years.
This examiner's interview lift is +58.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Emma Ruth Hoppe took 1,418 days on average from filing to allowance.
Emma Ruth Hoppe examines applications in Art Unit 1682 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
